We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current QURE market cap is 223.88M. The company's latest EPS is USD -6.4484 and P/E is -0.73.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.93M | 104.94M | 7.14M | 3.72M | 2.83M |
| Operating Income | -59.52M | 26.5M | -74.17M | -67.51M | -81.88M |
| Net Income | -47.86M | 6.81M | -77.23M | -68.47M | -89.57M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9.17M | 40.86M | 536.31M | 113.65M | 21.9M |
| Operating Income | -123.97M | -125.43M | 310.62M | -143.16M | -282.87M |
| Net Income | -130.63M | -125.02M | 329.59M | -126.79M | -308.48M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 638.23M | 704.96M | 631M | 942.77M | 871.55M |
| Total Liabilities | 217.06M | 228.96M | 218.23M | 589.45M | 602.77M |
| Total Equity | 421.17M | 476.01M | 412.77M | 353.32M | 268.78M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 448.63M | 340.4M | 809.18M | 704.96M | 831.69M |
| Total Liabilities | 125.57M | 96.49M | 213.4M | 228.96M | 624.02M |
| Total Equity | 323.06M | 243.91M | 595.78M | 476.01M | 207.67M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -90.38M | -145.06M | -78.3M | -135.3M | -96.39M |
| Investing | -14.52M | -182.73M | 2.99M | 48.82M | -265.25M |
| Financing | 844k | 1.45M | 131k | 370.27M | 362.68M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -98.68M | -134.83M | 287.96M | -145.06M | -145.93M |
| Investing | -6.65M | -9.48M | -67.39M | -182.73M | -205.69M |
| Financing | 248.82M | 7.44M | 94.86M | 1.45M | 362.72M |
| Market Cap | 223.88M |
| Price to Earnings Ratio | -0.73 |
| Price to Sales Ratio | 10.22 |
| Price to Cash Ratio | 0.93 |
| Price to Book Ratio | 1.08 |
| Dividend Yield | - |
| Shares Outstanding | 47.84M |
| Average Volume (1 week) | 576.96k |
| Average Volume (1 Month) | 615.6k |
| 52 Week Change | -76.72% |
| 52 Week High | 22.48 |
| 52 Week Low | 4.25 |
| Spread (Intraday) | 0.28 (5.86%) |
| Company Name | uniQure NV |
| Address |
paasheuvelweg 25a amsterdam, north holland 1105 BP |
| Website | https://www.uniqure.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
